Cancer patients can respond very differently to the same treatment, while current testing may not reliably identify the therapy most likely to work for each tumor.
R&D Focus
Gene editing and gene therapy for precision treatment
Innovative Solution
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform the future of targeted cancer treatment.
Investment Funding
Last Funding Stage
Series A
Total Funding Amount
28.M
Last Funding Amount
28.M
Last Funding Date
12-04-2023
Startup Stage
Early Stage
Lead Investors
Andreessen Horowitz, S32, Alexandria Venture Investments, Casdin Capital
Revenue
$1M to $10M
People
Founders
Christian Schmedt
Srihari Sampath
Srinath Sampath
About
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform to transform the future of targeted cancer treatment.
Something missing or incorrect on this page? Help us enrich this information
